GBT

Global Blood Therapeutics, Inc. Common Stock

$38.35 +$0.05 +0.13%



Shares Bought4
Shares Sold4
Total8
Shares Owned0
Last Price$38.35
Total Return$5.92
Range Today$37.73 - $39.00
52 Week Range$13.35 - $43.95
Open$38.30
Market Cap$1.66B
Volume/Average296.45K/966.38K
P/E Ratio-
Dividend/Yield-




Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-08-17 19:34 11-15-17 22:26 $38.99 $41.00 +$2.01 +5.14% xvpulsevx mistacat
11-08-17 19:38 11-15-17 22:25 $38.99 $41.00 +$2.01 +5.14% xvpulsevx
11-08-17 19:37 11-15-17 22:24 $38.99 $41.00 +$2.01 +5.14% xvpulsevx
11-08-17 19:31 11-08-17 19:35 $38.99 $38.90 -$0.09 -0.24% xvpulsevx